GOLDBERG MICHAEL B 4
4 · ENDO PHARMACEUTICALS HOLDINGS INC · Filed Nov 22, 2005
Insider Transaction Report
Form 4
KELSO EQUITY PARTNERS V L P
10% Owner
Transactions
- Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$2.42/sh−17,888$43,289→ 17,567,474 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$2.42/sh−7,712$18,663→ 17,559,762 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$2.42/sh−19,566$47,350→ 17,540,196 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$2.42/sh−3,885$9,402→ 17,536,312 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$3.00/sh−6,663$19,989→ 17,529,648 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$3.00/sh−9,628$28,884→ 17,520,020 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$3.00/sh−24,358$73,074→ 17,495,662 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
[F1][F2][F3]2005-11-17$3.42/sh−8,890$30,404→ 17,486,772 total(indirect: By LLC) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$2.42/sh−17,888$43,289→ 97,608 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (17,888 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$2.42/sh−7,712$18,663→ 62,201 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (7,712 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$2.42/sh−19,566$47,350→ 86,675 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (19,566 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$2.42/sh−3,885$9,402→ 42,685 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (3,885 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$3.00/sh−6,663$19,989→ 297,108 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (6,663 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$3.00/sh−9,628$28,884→ 28,351 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (9,628 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$3.00/sh−24,358$73,074→ 70,355 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (24,358 underlying) - Exercise of In-Money
Call Option (obligation to sell)
[F2][F3]2005-11-17$3.42/sh−8,890$30,404→ 27,535 total(indirect: By LLC)Exercise: $3.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (8,890 underlying)
Footnotes (3)
- [F1]Kelso Equity Partnes V, L.P. ("KEP V") is the designated filer.
- [F2]KEP V may be deemed to share beneficial ownership of shares of Common Stock owned of record by Endo Pharma LLC by virtue of its status as a member of Endo Pharma LLC. KEP V shares investment and voting power along with the other members of Endo Pharma LLC with respect to securities owned by Endo Pharma LLC, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest.
- [F3]Each individual reporting person may be deemed to share beneficial ownership of shares of Common Stock owned of record by KEP V, by virtue of his status as a general partner of the general partner of KEP V, and each individual shares investment and voting power along with the other general partners of KEP V, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest.
Signature
/s/James J. Connors, II|2005-11-22